Home» Medical News

FDA launches new organizational performance management system
Views: 96
Date: 03 Sep 2010
Definition of medical terminology for Food.
Definition of medical terminology for Government.
The U.S. Food and Drug Administration launched an innovative performance management system designed to advance the Presidents commitment to transparency, public participation, and collaboration in the work of government.

Definition of medical terminology for Measures.
Definition of medical terminology for Leadership.
Definition of medical terminology for Track.
Definition of medical terminology for Measure.
Definition of medical terminology for Goals.
Definition of medical terminology for Public Health.
Definition of medical terminology for Health.
The things we normally do in daily living including any daily activity we perform for self-care (such as feeding ourselves, bathing, dressing, grooming), work, homemaking, and leisure.
Definition of medical terminology for Government.
Definition of medical terminology for Level of Health.
Definition of medical terminology for Measures.
Definition of medical terminology for Measures.
Definition of medical terminology for Emergencies.
Definition of medical terminology for Measures.
Definition of medical terminology for Measures.
Definition of medical terminology for Goals.
Definition of medical terminology for Publications.
Definition of medical terminology for Industry.
Definition of medical terminology for Measures.
Definition of medical terminology for Measures.
Definition of medical terminology for Mission.
section of the Food, Drug, and Cosmetic Act that deals with premarket notification
Definition of medical terminology for Medical Assistance.
Definition of medical terminology for Device.
Definition of medical terminology for Goal.
Definition of medical terminology for Period Analyses.
Definition of medical terminology for Mission.
Definition of medical terminology for Office Automation.
Definition of medical terminology for Plan Implementation, Health.
Definition of medical terminology for Drugs.

The system, called FDA-TRACK, will monitor more than100 FDA program offices through data from key performance measures established each year. That data will be gathered monthly, analyzed and presented each quarter to FDA senior leadership.Importantly, the public will be able to track this data and the agencyas progress through the FDA-TRACK website.

aFDA-TRACK will bring the operations of this historically opaque Agency into the daylight and help us be even more responsive as we work to protect the public health,a said FDA Commissioner Margaret Hamburg, M.D.

FDA-TRACK is designed to be informative, encourage accountability among the people who work at the FDA, and make that work more transparent. It gives managers and employees a new way to measure their effectiveness in meeting goals to protect the public health and provides a way for the public to monitor agency activities .

Adapted from several successful state and local performance management models, FDA-TRACK hopes to set the standard for open government at the federal level . The system monitors performance indicators in four categories:

Common Measures a Agency-wide measures applicable to each of more than100 program offices and may focus on the agencyas most recent priorities.

Example: Increase the total number of employees who are trained in the Incident Command System, which helps the agency respond to emergencies.

Key Center Director Measures a Center-specific measures that are applicable to each Center and are central to the Centeras priorities and strategic goals.

Example: Increase the FDAas technical guidance by increasing the number of technical publications drafted, which enables the Center to better prepare industry and consumers.

Program Measures a Program office-specific measures that are applicable to the office and reflect work important to the public and to the FDAas mission.

Example: Monitor the percentage of 510(k) decisions meeting the 90-day Medical Device User Fee Act goal during a specific time period .

Key Projects a Program office-specific projects that are applicable to the office and important to the mission and objectives of the office . Performance for Key Projects is measured through achievement of the stated milestones within the projectas plan .

Example: The development of a new risk-based approach for evaluating safety, effectiveness, and quality of new animal drugs.


Source : DrugsFreeList.com
Tags: FDA

Latest Medical News

» U.S. Food And Drug Administration Approves Pfizers INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
-Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved INLYTA (axitinib), a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC)
29 Jan 2012 | Read


» Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for standard review of bosutinib as a treatment option for adult patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
29 Jan 2012 | Read


» FDA approves Inlyta to treat patients with a type of advanced kidney cancer
The U.S. Food and Drug Administration approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
29 Jan 2012 | Read


» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML).
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 27, 2012
New drugs approved. List of drugs approved by FDA to date January 27, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 26, 2012
New drugs approved. List of drugs approved by FDA to date January 26, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 25, 2012
New drugs approved.List of drugs approved by FDA to date January 25, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 24, 2012
New drugs approved. List of drugs approved by FDA to date January 24, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 23, 2012
New drugs approved.List of drugs approved by FDA to date January 23, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 20, 2012
New drugs approved. List of drugs approved by FDA to date January 20, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 19, 2012
New drugs approved. List of drugs approved by FDA to date January 19, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 18, 2012
New drugs approved. List of drugs approved by FDA to date January 18, 2012
29 Jan 2012 | Read


» FDA expands use of endovascular graft to treat aortic tears
The U.S. Food and Drug Administration expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-threatening tears or ruptures of the aorta (thoracic aortic transection).
19 Jan 2012 | Read


» FDA approves Voraxaze to treat patients with toxic methotrexate levels
The U.S. Food and Drug Administration approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.
19 Jan 2012 | Read


» FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)
The U.S. Food and Drug Administration (FDA) is notifying the public that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris (brentuximab vedotin).
19 Jan 2012 | Read


General Search

Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap